Cell And Gene Therapy Contract Research Organization Market Outlook Highlights The Next Major Growth Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cell And Gene Therapy Contract Research Organization Market Forecast: What Market Value Is Expected By 2030?
The cell and gene therapy contract research organization market size has experienced rapid expansion in recent years. This market is projected to expand from $6.92 billion in 2025 to reach $7.76 billion by 2026, reflecting a compound annual growth rate (CAGR) of 12.1%. Historically, this growth can be attributed to the increasing number of early-stage cell and gene therapy programs, limited in-house development capabilities, the expansion of rare disease research pipelines, rising regulatory complexity in advanced therapies, and an increasing reliance on external research expertise.
The cell and gene therapy contract research organization market size is anticipated to undergo significant expansion in the next few years. It is projected to grow to $12.36 billion by 2030, achieving a compound annual growth rate (CAGR) of 12.3%. The growth observed during the forecast period can be attributed to increased clinical trial activity in gene therapies, the expansion of personalized medicine development, rising investments in oncology and genetic disorder research, a growing demand for accelerated development timelines, and increased collaboration between biotech firms and CROs. Key trends for this period include a greater outsourcing of cell and gene therapy research, an increasing demand for integrated preclinical and clinical services, a growing focus on regulatory and compliance expertise, the expansion of vector development and manufacturing support, and an enhanced use of data-driven trial management.
Download A Free Sample Report For Comprehensive Market Insights:
Cell And Gene Therapy Contract Research Organization Market Development Factors: Which Trends Are Supporting Demand?
The increasing emphasis on personalized medicine and targeted therapeutics is anticipated to fuel the expansion of the cell and gene therapy contract research organization (CRO) market. These approaches focus on developing treatments precisely adapted to an individual’s unique genetic, molecular, or cellular makeup, aiming to enhance effectiveness and minimize unwanted side effects. The prominence of personalized medicine is growing because regulatory bodies and healthcare systems are increasingly prioritizing precision-based therapies to manage complex illnesses and achieve improved clinical outcomes. Cell and gene therapy contract research organizations (CROs) contribute to personalized medicine by offering expert preclinical, clinical, and regulatory services essential for the creation, assessment, and validation of intricate gene- and cell-based therapeutic products. As an illustration, in April 2025, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the Food and Drug Administration (FDA) gave its approval to 18 personalized medicines in 2024, representing approximately 38% of all newly approved therapeutic molecular entities. Consequently, the heightened attention to personalized medicine and targeted therapeutics is a key factor driving the growth of the cell and gene therapy contract research organization (CRO) market.
Cell And Gene Therapy Contract Research Organization Market Segmentation: How Is The Market Structured Across Key Categories?
The cell and gene therapy contract research organization market covered in this report is segmented –
1) By Type: Preclinical Contract Research Organization; Clinical Stage Contract Research Organization; Other Types
2) By Service: Project And Clinical Trial Management; Regulatory Strategy; Data Management And Medical Writing; Clinical Monitoring; Quality Management And Good Manufacturing Practice Compliance; Biostatistics And Safety Monitoring; Patient And Site Recruitment; Technology Transfer; Other Services
3) By Indication: Oncology; Central Nervous System Disorders; Infectious Diseases; Immunological Disorders; Cardiovascular Diseases; Respiratory Diseases; Diabetes; Ophthalmology; Pain Management; Other Indications
4) By Modality: Cell-Based Therapies; Gene Therapies; Gene-Modified Cell Therapies
5) By Application: Hospital; Research Institute; Other Applications
Subsegments:
1) By Preclinical Contract Research Organization: In Vitro Testing Services; In Vivo Animal Model Services; Toxicology And Safety Assessment; Other Preclinical Services
2) By Clinical Stage Contract Research Organization: Phase I Clinical Trial Services; Phase II Clinical Trial Services; Phase III Clinical Trial Services; Other Clinical Stage Services
3) By Other Types: Regulatory Consulting Services; Process Development Services; Manufacturing Support Services; Other Support Services
Cell And Gene Therapy Contract Research Organization Market Transformation Trends: Which Innovations Are Driving Change?
Major companies operating within the cell and gene therapy contract research organization (CRO) market are prioritizing the creation of innovative solutions, including expanded laboratory and analytical services, to improve therapy development efficiency, ensure regulatory compliance, and enhance research precision by offering advanced facilities, specialized equipment, and integrated cell and gene therapy testing capabilities. Expanded laboratory and analytical services describe contract research organization (CRO) offerings that boost capacity, enable the execution of complex assays, and support sponsors throughout the entire development process of advanced cell and gene therapies. For instance, in August 2025, Labcorp Holdings Inc., a US-based healthcare company, expanded its cell and gene therapy laboratory in madison, wisconsin, thereby strengthening its capabilities for cell characterization, vector analytics, and regulatory-compliant testing. This enlarged facility provides dedicated infrastructure for intricate cell and gene therapy workflows, supports high-throughput sample processing, and integrates advanced analytical platforms, making it a comprehensive solution for accelerating cell and gene therapy research and development.
Cell And Gene Therapy Contract Research Organization Market Competitive Landscape And Leading Companies
Major companies operating in the cell and gene therapy contract research organization market are Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings (Labcorp), ICON plc, WuXi AppTec Co. Ltd., Syneos Health Inc., Charles River Laboratories International Inc., Parexel International Corporation, Fortrea Holdings Inc., CMIC Co. Ltd., Medpace Holdings Inc., PharmaLex GmbH, Premier Research International LLC, Worldwide Clinical Trials Inc., Novotech (Australia) Pty Ltd., Precision for Medicine Inc., Syngene International Limited, Allucent Inc., TFS HealthScience AB, QPS Holdings LLC, Altasciences Company Inc., Veristat LLC, Linical Co. Ltd., Aixial Group, ProRelix Research LLC
Access The Complete Cell And Gene Therapy Contract Research Organization Market Report:
Cell And Gene Therapy Contract Research Organization Market Regional Analysis And Leading Geography
North America was the largest region in the cell and gene therapy contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy contract research organization market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
